Navigation Links
Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II
Date:1/31/2011

SHAWNEE, Kan., Jan. 31, 2011 /PRNewswire/ -- Bayer Animal Health announced this month at the North American Veterinary Conference, the availability of its new products:  Advantage® II for cats and dogs, and K9 Advantix® II for dogs.  These products combine the adulticidal properties of the original formulations of Advantage® Topical Solution and K9 Advantix®, with the insect growth regulator (IGR) pyriproxyfen, which inhibits the development of flea eggs and kills flea larvae.  As a result, Advantage® II and K9 Advantix® II kill all flea life stages and prevent fleas on a treated dog from infesting the home.  These products will be available in March 2011.  

Pyriproxyfen, the added compound in Advantage® II and K9 Advantix® II, interferes with the hormone signaling of growing insects so that fleas in immature stages are unable to mature.  The hormone pathway that pyriproxyfen targets is specific to insects and does not affect mammals.  

"Adding pyriproxyfen to the original formulations of Advantage® Topical Solution and K9 Advantix® gives an added layer of protection to our customers' pets and their pets' surroundings.  It interrupts the flea life cycle at multiple stages, and prevents reinfestation," said Peter Ryan, Vice President & Head, Companion Animal Business Unit, Bayer Animal Health.

Advantage® II and K9 Advantix® II have adulticidal, larvicidal and ovicidal properties, killing adult fleas and preventing the emergence of new ones.  Disrupting the flea life cycle through different active ingredients and modes of action is often referred to as integrated flea control (IFC).  Imidacloprid quickly paralyzes a flea's mouthparts and kills fleas through contact, so fleas don't have to bite your pet to die. By protecting pets from fleas, imidacloprid has been shown to reduce the incidence of certain conditions including flea allergy dermatitis.

"As part of our commitment to the well-being of companion animals, we continuously look for new ways to provide our customers with excellent pet protection products," said Joe Hostetler, DVM, Veterinary Services Manager, Bayer Animal Health. "Advantage® II and K9 Advantix® II build upon 14 years of imidacloprid's proven efficacy that veterinarians and pet owners have come to expect from Bayer Animal Health."

Advantage® II, the flea specialist, is a once-monthly topical solution for both dogs and cats, and includes an application for kittens less than five pounds.  

K9 Advantix® II offers five-way pest protection, repelling and killing ticks, fleas, mosquitoes, repelling biting flies and killing lice. K9 Advantix® II is for use on dogs only. Advantage® II and K9 Advantix® II are both waterproof.  See label directions for use.

About Bayer Animal Health

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. With sales of EUR 977 million (2009), Bayer's Animal Health business is one of the world's leading manufacturers of veterinary drugs. The division manufactures and markets approximately 100 different veterinary drugs and care products for food-supplying animals and companion animals.  U.S. Headquarters for Bayer Animal Health is located in Shawnee, KS.

© Bayer, the Bayer Cross, Advantage and K9 Advantix are registered trademarks of Bayer.


'/>"/>
SOURCE Bayer Animal Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
2. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
3. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
4. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
5. Prometheus and Bayer HealthCare Enter into Services Agreement to Conduct Mutational Analysis
6. Bayer Introduces Fitness Program for Children and Young Adults with Hemophilia A
7. Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress
8. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
9. Nick Jonas and Bayer Diabetes Care Enable Winners of the Give Back. Simply Win. Contest to Realize Their Dream to Help Others
10. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
11. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... 2016 Research and Markets ... Electronics 2015-2025: Applications, Technologies, Forecasts" report to ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, Composite ... Structural electronics involves electronic and/or electrical components and ... dumb structures such as vehicle bodies or conformally ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):